Engineering smart 3D silk fibroin tissue culture scaffolds using reactive inkjet printing
Engineering smart 3D silk fibroin tissue culture scaffolds using reactive inkjet printing
批准号:
EP/N007174/1
负责人:
Xiubo Zhao
金额:
$12.65万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --
中文摘要
人口老龄化、疾病增加和意外事故将导致未来十年对组织/器官移植的巨大需求。然而,由于严重缺乏捐赠和免疫不匹配,这些需求不太可能得到满足。组织工程和再生医学的突破将为构建适合移植的三维组织提供显着的成功。三维多孔支架在组织工程中发挥着重要作用,不仅作为组织制造的结构模板,而且还为细胞提供复杂的信号线索,并促进氧气和治疗剂的输送。因此,能否获得优良的三维支架成为制约组织工程快速发展的因素之一。优秀的3D支架的生产高度依赖于i)合适的制造技术和ii)优秀的候选生物材料。第一个拨款提案旨在利用新兴的增材制造技术(反应喷墨打印,RIJ)和独特的生物材料(再生丝素蛋白,RSF)制造智能3D组织培养支架。丝素蛋白是一种FDA批准的生物材料,具有良好的生物相容性、生物降解性和优异的力学性能,是组织工程/再生医学支架的理想材料。此外,蚕丝材料作为廉价原料在世界范围内广泛使用,并且主要用作纺织工业中的低技术/利润材料。在高科技/高利润行业中,丝绸作为先进材料有很大的开发空间。其中一个备受关注的应用是开发适合于组织支架制造的生物材料。然而,目前通过传统方法(例如铸造、冷冻干燥、静电纺丝)制成的RSF支架具有简单的结构,仅适用于实验室研究或非常基础的组织工程。必须找到合适的制造技术来制造先进的3D支架,以提供更有效的微尺度控制。RIJ的优势不仅在于计算机辅助设计(CAD),其在预定位置提供皮升(1 e-12升)油墨的精确递送,并且允许制造复杂的3D架构,而且还在于不同油墨的交替递送(通过不同的打印头),其允许在制造和操纵支架的组合物和性质期间控制反应。因此,RSF材料和RIJ技术的结合为未来再生医学制造更好的3D支架提供了一个有希望的机会。
英文摘要
Population aging, increased diseases and unexpected accidents will result in huge demands of tissue/organ transplantation over the next decade. However, the demands are unlikely to be met due to the significant lack of donation and immune mismatching. The breakthrough of tissue engineering and regenerative medicine will offer remarkable success in building three-dimensional tissues suitable for transplantation. 3D porous scaffolds play important roles in tissue engineering not only as structural templates for tissue fabrication but also providing complex signaling cues to cells and facilitating oxygen and therapeutic agent delivery. Therefore, the availability of excellent 3D scaffolds has become one of the aspects that constrains the fast developing of tissue engineering. Production of excellent 3D scaffolds highly relies on i) suitable fabrication technology and ii) excellent candidate biomaterials. This first grant proposal seeks to harness the emerging additive manufacturing technology (reactive inkjet printing, RIJ) and the unique biomaterial (regenerated silk fibroin, RSF) for the fabrication of smart 3D tissue culture scaffolds. Silk fibroin (a FDA approved biomaterial) is well known for its good biocompatibility, biodegradability, and excellent mechanical properties, therefore, is an ideal candidate as scaffold for tissue engineering/regenerative medicine. Moreover, silk material is widely available worldwide as a cheap feedstock and is mostly used as low-tech/profit material in textile industry. There is plenty of room for exploiting silk as advanced material in high tech/profit industries. One of the applications that have attracted much attention is to develop biomaterials suitable for the fabrication of tissue scaffolds. However, the current RSF scaffolds made through traditional methods (e.g. casting, freeze-drying, electrospinning) have simple structures that are only suitable for lab research or very basic tissue engineering. A suitable manufacturing technology must be found for making advanced 3D scaffolds that provide more effective controls in micro scales. The advantages of RIJ are not only the computer assisted design (CAD) that offers the precise delivery of pico-litres (1e-12 litre) of ink at predetermined locations and that allows the fabrication of complex 3D architectures but also the alternate delivery of different inks (through different print heads) that allows the control of reactions during manufacturing and manipulation of the compositions and the properties of the scaffolds. Therefore, the combination of RSF material and the RIJ technology provide a promising opportunity for fabricating better 3D scaffolds for future regenerative medicine.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2352/issn.2169-4451.2017.32.452
发表时间:
2016-09
期刊:
NIP & Digital Fabrication Conference
影响因子:
--
作者:
[D. Gregory;Y. Zhang;Patrick J. Smith;S. Ebbens;Xiubo Zhao]
通讯作者:
D. Gregory;Y. Zhang;Patrick J. Smith;S. Ebbens;Xiubo Zhao
DOI:
10.1021/acsami.1c14761
发表时间:
2021-10-18
期刊:
ACS APPLIED MATERIALS & INTERFACES
影响因子:
9.5
作者:
[Cirillo, Silvia, Tomeh, Mhd Anas, Zhao, Xiubo]
通讯作者:
Zhao, Xiubo
Reactive Inkjet Printing and Propulsion Analysis of Silk-based Self-propelled Micro-stirrers.
丝基自驱动微搅拌器的反应喷墨打印和推进分析。
DOI:
10.3791/59030
发表时间:
2019
期刊:
JoVE
影响因子:
--
作者:
[Gregory DA]
通讯作者:
Gregory DA
Reactive Inkjet Printing: Reactive Inkjet Printing of Biocompatible Enzyme Powered Silk Micro-Rockets (Small 30/2016)
反应喷墨印刷:生物相容性酶驱动丝微火箭的反应喷墨印刷(小30/2016)
DOI:
10.1002/smll.201670148
发表时间:
2016
期刊:
Small
影响因子:
13.3
作者:
[Gregory D]
通讯作者:
Gregory D
DOI:
10.1016/j.bbrc.2023.02.026
发表时间:
2023-02
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Roja Hadianamrei;Mhd Anas Tomeh;Jiqian Wang;Stephen Brown;Xiubo Zhao]
通讯作者:
Roja Hadianamrei;Mhd Anas Tomeh;Jiqian Wang;Stephen Brown;Xiubo Zhao
Fabrication of antibody functionalized silk fibroin micro-well arrays using reactive inkjet printing for circulating tumour cell capture
-
批准号:EP/N023579/1
-
项目类别:Research Grant
-
资助金额:$42.51万
-
财政年份:2016
-
负责人:Xiubo Zhao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于SMART技术的鳄梨叶中诱导肿瘤细胞铁死亡的先导化合物的定
向挖掘
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:辛颖
-
依托单位:
基于“活性-代谢组-基因组-SMART”整合策略发掘老鼠簕内生放线菌新型先导化合物
-
批准号:82360696
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:卢覃培
-
依托单位:
特定微环境激活的mRNA翻译(SMART)系统的设计及其免疫治疗应用研究
-
批准号:22307121
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:左超
-
依托单位:
基于ANDSystem与多组学的水稻和小麦胁迫响应分子调控网络及智能作物平台(Smart Crop)的构建
-
批准号:--
-
项目类别:--
-
资助金额:105万元
-
批准年份:2022
-
负责人:陈铭
-
依托单位:
精神障碍出院患者自杀风险简短联系干预(BCIs)的实施科学研究:基于序列多次分组的随机对照试验(SMART)
-
批准号:72004140
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:侯丰苏
-
依托单位:
线上强化失眠认知行为治疗(Smart-CBTI plus)对失眠障碍合并焦虑、抑郁患者的随机对照研究
-
批准号:20Y11906600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:苑成梅
-
依托单位:
基于SMART设计建立中医药随机对照试验“随证施治”决策模型的研究
-
批准号:82074584
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2020
-
负责人:荆志伟
-
依托单位:
DRiPs致病性T细胞与胰腺CUZD-1蛋白双靶向Smart-DDS诱导免疫耐受治疗1型糖尿病的研究
-
批准号:81970707
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:许馨予
-
依托单位:
基于B-SMART的类风湿关节炎分级诊疗的药物治疗管理模式构建与评价
-
批准号:71804109
-
项目类别:青年科学基金项目
-
资助金额:16.5万元
-
批准年份:2018
-
负责人:张乐
-
依托单位:
共表达E.stiedai MIC-5和RHDV VP60重组痘苗病毒构建及免疫机制研究
-
批准号:31160503
-
项目类别:地区科学基金项目
-
资助金额:48.0万元
-
批准年份:2011
-
负责人:井波
-
依托单位: